Screening for conditions that do not meet the Wilson and Jungner criteria: The case of Duchenne muscular dystrophy

@article{Ross2006ScreeningFC,
  title={Screening for conditions that do not meet the Wilson and Jungner criteria: The case of Duchenne muscular dystrophy},
  author={Lainie Friedman Ross},
  journal={American Journal of Medical Genetics Part A},
  year={2006},
  volume={140A}
}
  • L. Ross
  • Published 15 April 2006
  • Medicine
  • American Journal of Medical Genetics Part A
In this manuscript, I examine four overlapping policy and ethical issues regarding screening newborns (and infants) for Duchenne muscular dystrophy (DMD). First, what are the risks and benefits of expanding newborn screening (NBS) to include DMD? Second, if NBS were to expand to include DMD, should it require informed consent? Third, should NBS for DMD be limited to boys? Why or why not? Fourth, when is the ideal timing for screening (prenatal, newborn, or later in infancy) and what factors… 
Duchenne muscular dystrophy and reproductive decision-making : implications of newborn screening
TLDR
There is a need for greater consideration of the true value of providing information, "choice" and support in newborn screening and the implications of screening for untreatable conditions, including Duchenne muscular dystrophy.
Parental attitudes toward newborn screening for Duchenne/Becker muscular dystrophy and spinal muscular atrophy
TLDR
There was strong support for NBS for DMD, BMD, and SMA in both groups of parents, and discussion of inclusion in NBS should continue.
Cystic fibrosis newborn screening: A model for neuromuscular disease screening?
TLDR
The future path of NBS for these disorders with particular emphasis on DMD NBS is discussed, because of the likely approval of new gene‐modifying treatments, the possible benefits of earlier treatment with corticosteroids, and the recently demonstrated feasibility of a 2‐tiered approach to NBS.
Newborn Screening for Fragile X Syndrome: Do We Care What Parents Think?
TLDR
The response of new parents to offers of newborn screening for fragile X syndrome is described, and a larger question is whether the authors should care what parents think.
Duchenne muscular dystrophy: issues in expanding newborn screening
TLDR
Data are insufficient to recommend routine newborn screening for Duchenne muscular dystrophy, and studies are needed to evaluate the potential risks and benefits of screening, including the associated incremental costs.
Clinic-Based Infant Screening for Duchenne Muscular Dystrophy: A Feasibility Study
TLDR
DMD screening is feasible in a pediatric office when conducted as part of a research study and eventually could be offered in pediatric health care provider offices as an optional public health service outside of newborn screening.
Newborn screening for lysosomal storage diseases: an ethical and policy analysis
  • L. Ross
  • Medicine
    Journal of Inherited Metabolic Disease
  • 2011
TLDR
This manuscript evaluates three lysosomal storage diseases included in this multiplex screening test—Pompe disease, Fabry disease, and Krabbe disease and shows that they fail to meet some of the critical Wilson and Jungner criteria and thus are not ready for inclusion in universal NBS panels.
Screening for Klinefelter syndrome
Purpose of reviewTo examine recently published evidence that may inform the need for population screening of Klinefelter syndrome; by far the most common chromosomal disorder in males, which most
Clinical Follow‐Up for Duchenne Muscular Dystrophy Newborn Screening: A Proposal
TLDR
Clinical guidance to be implemented consistently in specialty care clinics charged with the care of presymptomatically identified newborns referred after DMD‐NBS is developed and could be used to provide consistent care across centers and serve as the basis for ongoing quality improvement.
Parental perspectives on the diagnostic process for Duchenne and Becker muscular dystrophy
TLDR
Parents' perceptions of the diagnostic process and factors that influence the timeline should initiate debate among system administrators, patient advocates, and healthcare providers regarding which barriers may be most modifiable and which interventions may reduce the time to diagnosis and limit parental emotional distress.
...
...

References

SHOWING 1-10 OF 122 REFERENCES
Experience with screening newborns for Duchenne muscular dystrophy in Wales.
TLDR
The acceptability of screening newborn boys for Duchenne muscular dystrophy should continue to permit a full evaluation of the issues involved and should serve as a model for other initiatives within the community for genetic disease.
Developmental progress in Duchenne muscular dystrophy: lessons for earlier detection.
  • E. Parsons, A. Clarke, D. Bradley
  • Medicine
    European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society
  • 2004
Impact of genetic counselling after neonatal screening for Duchenne muscular dystrophy.
TLDR
It is concluded that, although molecular genetic analysis now allows for precise diagnosis of DMD, highly accurate carrier testing and prenatal diagnosis, very early DMD carrier identification, and genetic counselling after the identification of DMT males in a population based neonatal screening programme may not be an effective way of decreasing the number of repeat cases of D MD within families or the overall population frequency.
Pediatricians' Attitudes Toward Expanding Newborn Screening
TLDR
Most physicians support diagnostic genetic testing of high-risk children but are less supportive of expanding newborn screening, particularly for conditions that do not meet the Wilson and Jungner criteria.
Newborn screening for Duchenne muscular dystrophy: a psychosocial study
TLDR
A case can be made for newborn screening for Duchenne muscular dystrophy provided that the test is optional, a rigorous protocol for service delivery is used, and an infrastructure providing continuing support is in place.
Feasibility of a Change in Service Delivery: The Case of Optional Newborn Screening for Duchenne Muscular Dystrophy
TLDR
The new procedure was shown to be feasible for midwives, laboratory staff and the majority of parents, but there are, however, added burdens and added benefits to both service provider and service user which need to be taken into account.
Newborn screening for Duchenne muscular dystrophy.
TLDR
A new method to reliably determine CPK in a drop of dried blood is described and it is proposed to adopt the method as a new screening procedure for male newborn infants.
Parental attitudes regarding newborn screening of PKU and DMD
TLDR
Professional guidelines that proscribe predictive testing for untreatable childhood onset conditions should be re‐examined in light of consumer attitudes, according to focus groups.
...
...